Self-Assembling, Biomimetic Membranes May Aid Water Filtration
News Aug 03, 2015
This biomimetic membrane is composed of lipids -- fat molecules -- and protein-appended molecules that form water channels that transfer water at the rate of natural membranes, and self-assembles into 2-dimensional structures with parallel channels.
"Nature does things very efficiently and transport proteins are amazing machines present in biological membranes," said Manish Kumar, assistant professor of chemical engineering, Penn State. "They have functions that are hard to replicate in synthetic systems."
The researchers developed a second-generation synthetic water channel that improves on earlier attempts to mimic aquaporins – natural water channel proteins -- by being more stable and easier to manufacture. The peptide-appended pillararenes (PAP) are also more easily produced and aligned than carbon nanotubes, another material under investigation for membrane separation.
"We were surprised to see transport rates approaching the 'holy grail' number of a billion water molecules per channel per second," said Kumar. "We also found that these artificial channels like to associate with each other in a membrane to make 2-dimensional arrays with a very high pore density."
The researchers consider that the PAP membranes are an order of magnitude better than the first-generation artificial water channels reported to date. The propensity for these channels to automatically form densely packed arrays leads to a variety of engineering applications.
"The most obvious use of these channels is perhaps to make highly efficient water purification membranes," said Kumar.
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE